MOLTHERA

MOLTHERA Launches Redesigned Corporate Website
JUPITER, Florida — August 5, 2026 — MOLTHERA today announced the launch of its redesigned corporate website, providing an updated overview of the company’s scientific strategy, development portfolio, and approach to building precision technologies for inflammatory disease and solid tumors.
The new website reflects MOLTHERA’s integrated development model:
Build the molecule. Map the biology. Localize the effect.
MOLTHERA is advancing a proprietary portfolio spanning engineered biologics, molecular imaging, extracellular-matrix modulation, and localized delivery. The website presents the company’s programs at a nonconfidential level while preserving technical details for appropriate scientific, strategic, and development discussions.
“Our goal was to create a clear public-facing representation of how MOLTHERA approaches complex disease biology. The new site brings together our work across molecular engineering, translational biology, imaging, and spatially controlled intervention under one coherent development strategy.”
The website also introduces a dedicated News section where MOLTHERA will publish selected company updates, research milestones, collaboration announcements, and other developments.
About MOLTHERA
MOLTHERA is an emerging biotechnology company developing proprietary biologics, molecular imaging programs, and localized delivery technologies for inflammatory disease and oncology. The company integrates molecular engineering, translational biology, and spatially controlled intervention to address complex disease microenvironments.
Contact
Business Development and Media Inquiries
contact@molthera.com